Oncology & Cancer

Ыtudy documents head and neck cancer molecular tumor subtypes

Head and neck squamous cell carcinoma (HNSCC) is the seventh most common form of cancer in the United States, but other than an association with the human papillomavirus, no validated molecular profile of the disease has ...

Oncology & Cancer

New test predicted presence of harmful BRCA mutations

A new multiple gene expression profile test was able to predict the presence of harmful BRCA1 or BRCA2 mutations in otherwise healthy women carrying the mutations, according to data published in Cancer Prevention Research, ...

Oncology & Cancer

Expression, genomic patterns predict sarcoma progression

(HealthDay)—The Complexity Index in Sarcoma (CINSARC) and Genomic Index prognostic signatures are valid independent methods of assessing synovial sarcoma (SS) prognosis, according to a study published online Jan. 14 in ...

Oncology & Cancer

Team finds gene that promotes drug resistance in cancer

Scientists from the University of Iowa and Brigham Young University (BYU) have identified a gene that may be a target for overcoming drug resistance in cancer. The finding could not only improve prognostic and diagnostic ...

Oncology & Cancer

Cancer study overturns current thinking about gene activation

(Medical Xpress)—A new Australian study led by Professor Susan Clark from Sydney's Garvan Institute of Medical Research shows that large regions of the genome – amounting to roughly 2% – are epigenetically activated ...

Genetics

Valuable tool for predicting pain genes in people

Scientists in Australia and Austria have described a "network map" of genes involved in pain perception. The work, published in the journal PLOS Genetics should help identify new analgesic drugs.

page 10 from 12